183 related articles for article (PubMed ID: 24120763)
1. Structure of FGFR3 transmembrane domain dimer: implications for signaling and human pathologies.
Bocharov EV; Lesovoy DM; Goncharuk SA; Goncharuk MV; Hristova K; Arseniev AS
Structure; 2013 Nov; 21(11):2087-93. PubMed ID: 24120763
[TBL] [Abstract][Full Text] [Related]
2. NMR-based approach to measure the free energy of transmembrane helix-helix interactions.
Mineev KS; Lesovoy DM; Usmanova DR; Goncharuk SA; Shulepko MA; Lyukmanova EN; Kirpichnikov MP; Bocharov EV; Arseniev AS
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):164-72. PubMed ID: 24036227
[TBL] [Abstract][Full Text] [Related]
3. FGFR3 dimer stabilization due to a single amino acid pathogenic mutation.
Li E; You M; Hristova K
J Mol Biol; 2006 Feb; 356(3):600-12. PubMed ID: 16384584
[TBL] [Abstract][Full Text] [Related]
4. The pathogenic A391E mutation in FGFR3 induces a structural change in the transmembrane domain dimer.
Mudumbi KC; Julius A; Herrmann J; Li E
J Membr Biol; 2013 Jun; 246(6):487-93. PubMed ID: 23727984
[TBL] [Abstract][Full Text] [Related]
5. FGFR3 unliganded dimer stabilization by the juxtamembrane domain.
Sarabipour S; Hristova K
J Mol Biol; 2015 Apr; 427(8):1705-14. PubMed ID: 25688803
[TBL] [Abstract][Full Text] [Related]
6. Characterization of membrane protein interactions in plasma membrane derived vesicles with quantitative imaging Förster resonance energy transfer.
Sarabipour S; Del Piccolo N; Hristova K
Acc Chem Res; 2015 Aug; 48(8):2262-9. PubMed ID: 26244699
[TBL] [Abstract][Full Text] [Related]
7. Hill coefficient analysis of transmembrane helix dimerization.
Soong R; Merzlyakov M; Hristova K
J Membr Biol; 2009 Jul; 230(1):49-55. PubMed ID: 19603128
[TBL] [Abstract][Full Text] [Related]
8. Role of the N-Terminal Transmembrane Helix Contacts in the Activation of FGFR3.
Matsuoka D; Kamiya M; Sato T; Sugita Y
J Comput Chem; 2020 Mar; 41(6):561-572. PubMed ID: 31804721
[TBL] [Abstract][Full Text] [Related]
9. Effect of the achondroplasia mutation on FGFR3 dimerization and FGFR3 structural response to fgf1 and fgf2: A quantitative FRET study in osmotically derived plasma membrane vesicles.
Sarabipour S; Hristova K
Biochim Biophys Acta; 2016 Jul; 1858(7 Pt A):1436-42. PubMed ID: 27040652
[TBL] [Abstract][Full Text] [Related]
10. FGFR3 transmembrane domain interactions persist in the presence of its extracellular domain.
Sarabipour S; Hristova K
Biophys J; 2013 Jul; 105(1):165-71. PubMed ID: 23823235
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and initial characterization of FGFR3 transmembrane domain: consequences of sequence modifications.
Iwamoto T; You M; Li E; Spangler J; Tomich JM; Hristova K
Biochim Biophys Acta; 2005 Mar; 1668(2):240-7. PubMed ID: 15737335
[TBL] [Abstract][Full Text] [Related]
12. Dimer interface of transmembrane domains for neu/erbB-2 receptor dimerization and transforming activation: a model revealed by molecular dynamics simulations.
Sajot N; Genest M
J Biomol Struct Dyn; 2001 Aug; 19(1):15-31. PubMed ID: 11565846
[TBL] [Abstract][Full Text] [Related]
13. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis and forster resonance energy transfer suggest weak interactions between fibroblast growth factor receptor 3 (FGFR3) transmembrane domains in the absence of extracellular domains and ligands.
Li E; You M; Hristova K
Biochemistry; 2005 Jan; 44(1):352-60. PubMed ID: 15628877
[TBL] [Abstract][Full Text] [Related]
14. Primary and secondary dimer interfaces of the fibroblast growth factor receptor 3 transmembrane domain: characterization via multiscale molecular dynamics simulations.
Reddy T; Manrique S; Buyan A; Hall BA; Chetwynd A; Sansom MS
Biochemistry; 2014 Jan; 53(2):323-32. PubMed ID: 24397339
[TBL] [Abstract][Full Text] [Related]
15. Left-handed dimer of EphA2 transmembrane domain: Helix packing diversity among receptor tyrosine kinases.
Bocharov EV; Mayzel ML; Volynsky PE; Mineev KS; Tkach EN; Ermolyuk YS; Schulga AA; Efremov RG; Arseniev AS
Biophys J; 2010 Mar; 98(5):881-9. PubMed ID: 20197042
[TBL] [Abstract][Full Text] [Related]
16. Spatial structure and dimer--monomer equilibrium of the ErbB3 transmembrane domain in DPC micelles.
Mineev KS; Khabibullina NF; Lyukmanova EN; Dolgikh DA; Kirpichnikov MP; Arseniev AS
Biochim Biophys Acta; 2011 Aug; 1808(8):2081-8. PubMed ID: 21575594
[TBL] [Abstract][Full Text] [Related]
17. Transmembrane helix heterodimerization in lipid bilayers: probing the energetics behind autosomal dominant growth disorders.
Merzlyakov M; You M; Li E; Hristova K
J Mol Biol; 2006 Apr; 358(1):1-7. PubMed ID: 16500676
[TBL] [Abstract][Full Text] [Related]
18. Studies of receptor tyrosine kinase transmembrane domain interactions: the EmEx-FRET method.
Merzlyakov M; Chen L; Hristova K
J Membr Biol; 2007 Feb; 215(2-3):93-103. PubMed ID: 17565424
[TBL] [Abstract][Full Text] [Related]
19. Dimeric structure of transmembrane domain of amyloid precursor protein in micellar environment.
Nadezhdin KD; Bocharova OV; Bocharov EV; Arseniev AS
FEBS Lett; 2012 Jun; 586(12):1687-92. PubMed ID: 22584060
[TBL] [Abstract][Full Text] [Related]
20. The achondroplasia mutation does not alter the dimerization energetics of the fibroblast growth factor receptor 3 transmembrane domain.
You M; Li E; Hristova K
Biochemistry; 2006 May; 45(17):5551-6. PubMed ID: 16634636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
